Sein Adjuvant
BREASTIMMUNE03 / CA209-9XD
Evaluate the Clinical Benefit of a Post-operative Treatment Associating Radiotherapy + Nivolumab + Ipilimumab Versus Radiotherapy + Capecitabine for Triple Negative Breast Cancer Patients With Residual Disease (BreastImmune03)
Paris, Saint-Cloud
JEAN-YVES PIERGA, JEAN-YVES PIERGA